But what many don't know is that Moderna has only been around for a little over a decade. From cancelled conferences to disrupted supply chains, not a corner of the global economy is immune to the spread of COVID When it was formed inModerna developed its entire drug discovery and manufacturing processes around digital or the idea of being infused by artificial intelligence.
The first clinical grade batch was released on February 7, and the first subject was dosed on March 16 -- only 65 days from sequence to dosing. Johnson said Moderna ran the clinical studies to prove the effectiveness of its vaccine straight away, reaching milestones so quickly due to the programmable nature of mRNA and the platform the company built.
By creating your own synthetic mRNA, we can encode information for any protein we want from critical enzymes that might be malfunctioning in a rare disease, to an antigen from a virus to trigger an immune response, which creates a vaccine.
He said when Moderna was founded, it was on the understanding that if this mRNA technology worked for one application, it could work for countless more, and all that would be needed was to change the information and code it for a new application. Home Innovation.
The biotech firm was built in the cloud and, as a result, it's been able to speed up every step of the process required to develop a COVID vaccine. It now has plans to take its learnings further to revolutionise the way diseases are treated.
Written by Asha Barbaschow, Contributor on May 17, Show Comments. Log In to Comment Community Guidelines.